Patents by Inventor David S. Dresback

David S. Dresback has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220265636
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: August 18, 2021
    Publication date: August 25, 2022
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Publication number: 20200022971
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: May 29, 2019
    Publication date: January 23, 2020
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Publication number: 20160235736
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: February 12, 2016
    Publication date: August 18, 2016
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Patent number: 9409896
    Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: August 9, 2016
    Assignee: Melinta Therapeutics, Inc.
    Inventors: Eric S. Burak, Danping Li, David S. Dresback
  • Publication number: 20140094463
    Abstract: The present invention relates to carrier systems useful for pharmaceutical compositions. These carriers comprise an emulsifier, and also in further embodiments a polymeric dissolution aid. These carriers are useful for delivering pharmaceutical actives such as antimicrobial agents.
    Type: Application
    Filed: November 1, 2011
    Publication date: April 3, 2014
    Applicant: RIB-X PHARMACEUTICALS, INC.
    Inventors: Eric S. Burak, Danping Li, David S. Dresback
  • Publication number: 20120065186
    Abstract: The present invention relates to antimicrobial compositions and more specifically compositions of quinolone carboxylic acid derivatives. These compositions have improved solubility, stability, and tolerability. These compositions are useful for intravenous administration for treating, preventing, or reducing the risk of infection.
    Type: Application
    Filed: May 11, 2011
    Publication date: March 15, 2012
    Inventors: Danping LI, Eric S. BURAK, David S. DRESBACK, Danielle B. LORD
  • Patent number: 4220152
    Abstract: Delivery systems and devices for the controlled release of chemicals, including drugs, comprising a wall, formed in part at least, of a porous material, pores of which contain a hydrogel, said porous wall in contact with at least a portion of a reservoir comprised of a chemical and, if desired, a water-soluble liquid excipient and/or a detergent; process for preparation thereof, and use for the controlled release of chemicals, including drugs, to an aqueous liquid-containing environment. Emphasis is given to said systems and devices in which the porous material is a sintered plastic and gelled cellulose triacetate is the hydrogel, and to their use for controlled release of drugs to animals, especially to ruminants over prolonged periods of time.
    Type: Grant
    Filed: February 22, 1979
    Date of Patent: September 2, 1980
    Assignee: Pfizer Inc.
    Inventor: David S. Dresback
  • Patent number: 4220153
    Abstract: Delivery systems and devices for the controlled release of chemicals, including drugs, comprising a wall, formed in part at least, of a porous fabric material, pores of which contain a hydrogel, said porous wall in contact with at least a portion of a reservoir comprised of a chemical and, if desired, a water-soluble liquid excipient and/or a detergent; process for preparation thereof, and use for the controlled release of chemicals, including drugs, to an aqueous liquid-containing environment. Emphasis is given to said systems and devices in which the porous fabric material is a synthetic fabric and gelled cellulose triacetate is the hydrogel, and to their use for controlled release of drugs to animals, especially to ruminants, over prolonged periods of time.
    Type: Grant
    Filed: February 22, 1979
    Date of Patent: September 2, 1980
    Assignee: Pfizer Inc.
    Inventor: David S. Dresback